Oral immunisation as a strategy for enhancing corneal allograft survival

Ding Ma, Jessamee Mellon, Jerry Y. Niederkorn

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Aims--To determine optimal conditions for enhancing corneal allograft survival through oral administration of donor specific corneal cells. Methods--A mouse model of penetrating keratoplasty was used to evaluate the efficacy and optimal conditions for preventing immunological rejection of corneal allografts. C3H corneal grafts were transplanted orthotopically to CB6F1 recipients and represented mismatches at the entire major histocompatibility complex (MHC) and multiple minor histocompatibility loci. Tissue cultured C3H corneal epithelial and endothelial cells were administered orally to CB6F1 mice before or shortly after the application of orthotopic C3H corneal allografts. Cultured C3H corneal cells were conjugated with the non-toxic B subunit of cholera toxin as a means of preferentially inducing oral tolerance. Results--Ten oral doses of donor cells administered before keratoplasty reduced the incidence of corneal graft rejection from 100% in untreated hosts to 54% in orally tolerised mice. Conjugation of cholera toxin to corneal cells significantly enhanced the efficacy of oral tolerance such that only 9% of the mice fed 10 doses of cholera toxin conjugated cells rejected their corneal grafts. Even a single oral inoculation of corneal cells conjugated to cholera toxin was able to reduce corneal graft rejection by 36%. Conclusions--Oral administration of donor specific cells greatly enhances corneal graft survival. Use of cholera toxin adjuvant markedly enhances the efficacy of oral tolerance such that even a single oral dose of donor cells significantly reduces the incidence of rejection. The results support the clinical feasibility of this novel strategy for preventing immunological rejection of corneal transplants.

Original languageEnglish (US)
Pages (from-to)778-784
Number of pages7
JournalBritish Journal of Ophthalmology
Volume81
Issue number9
StatePublished - Sep 1997

Fingerprint

Allografts
Immunization
Cholera Toxin
Graft Rejection
Minor Histocompatibility Loci
Oral Administration
Transplants
Penetrating Keratoplasty
Corneal Transplantation
Incidence
Graft Survival
Major Histocompatibility Complex
Endothelial Cells
Epithelial Cells

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Oral immunisation as a strategy for enhancing corneal allograft survival. / Ma, Ding; Mellon, Jessamee; Niederkorn, Jerry Y.

In: British Journal of Ophthalmology, Vol. 81, No. 9, 09.1997, p. 778-784.

Research output: Contribution to journalArticle

@article{ea01546cc6594afa9e38d4a9cefed022,
title = "Oral immunisation as a strategy for enhancing corneal allograft survival",
abstract = "Aims--To determine optimal conditions for enhancing corneal allograft survival through oral administration of donor specific corneal cells. Methods--A mouse model of penetrating keratoplasty was used to evaluate the efficacy and optimal conditions for preventing immunological rejection of corneal allografts. C3H corneal grafts were transplanted orthotopically to CB6F1 recipients and represented mismatches at the entire major histocompatibility complex (MHC) and multiple minor histocompatibility loci. Tissue cultured C3H corneal epithelial and endothelial cells were administered orally to CB6F1 mice before or shortly after the application of orthotopic C3H corneal allografts. Cultured C3H corneal cells were conjugated with the non-toxic B subunit of cholera toxin as a means of preferentially inducing oral tolerance. Results--Ten oral doses of donor cells administered before keratoplasty reduced the incidence of corneal graft rejection from 100{\%} in untreated hosts to 54{\%} in orally tolerised mice. Conjugation of cholera toxin to corneal cells significantly enhanced the efficacy of oral tolerance such that only 9{\%} of the mice fed 10 doses of cholera toxin conjugated cells rejected their corneal grafts. Even a single oral inoculation of corneal cells conjugated to cholera toxin was able to reduce corneal graft rejection by 36{\%}. Conclusions--Oral administration of donor specific cells greatly enhances corneal graft survival. Use of cholera toxin adjuvant markedly enhances the efficacy of oral tolerance such that even a single oral dose of donor cells significantly reduces the incidence of rejection. The results support the clinical feasibility of this novel strategy for preventing immunological rejection of corneal transplants.",
author = "Ding Ma and Jessamee Mellon and Niederkorn, {Jerry Y.}",
year = "1997",
month = "9",
language = "English (US)",
volume = "81",
pages = "778--784",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "9",

}

TY - JOUR

T1 - Oral immunisation as a strategy for enhancing corneal allograft survival

AU - Ma, Ding

AU - Mellon, Jessamee

AU - Niederkorn, Jerry Y.

PY - 1997/9

Y1 - 1997/9

N2 - Aims--To determine optimal conditions for enhancing corneal allograft survival through oral administration of donor specific corneal cells. Methods--A mouse model of penetrating keratoplasty was used to evaluate the efficacy and optimal conditions for preventing immunological rejection of corneal allografts. C3H corneal grafts were transplanted orthotopically to CB6F1 recipients and represented mismatches at the entire major histocompatibility complex (MHC) and multiple minor histocompatibility loci. Tissue cultured C3H corneal epithelial and endothelial cells were administered orally to CB6F1 mice before or shortly after the application of orthotopic C3H corneal allografts. Cultured C3H corneal cells were conjugated with the non-toxic B subunit of cholera toxin as a means of preferentially inducing oral tolerance. Results--Ten oral doses of donor cells administered before keratoplasty reduced the incidence of corneal graft rejection from 100% in untreated hosts to 54% in orally tolerised mice. Conjugation of cholera toxin to corneal cells significantly enhanced the efficacy of oral tolerance such that only 9% of the mice fed 10 doses of cholera toxin conjugated cells rejected their corneal grafts. Even a single oral inoculation of corneal cells conjugated to cholera toxin was able to reduce corneal graft rejection by 36%. Conclusions--Oral administration of donor specific cells greatly enhances corneal graft survival. Use of cholera toxin adjuvant markedly enhances the efficacy of oral tolerance such that even a single oral dose of donor cells significantly reduces the incidence of rejection. The results support the clinical feasibility of this novel strategy for preventing immunological rejection of corneal transplants.

AB - Aims--To determine optimal conditions for enhancing corneal allograft survival through oral administration of donor specific corneal cells. Methods--A mouse model of penetrating keratoplasty was used to evaluate the efficacy and optimal conditions for preventing immunological rejection of corneal allografts. C3H corneal grafts were transplanted orthotopically to CB6F1 recipients and represented mismatches at the entire major histocompatibility complex (MHC) and multiple minor histocompatibility loci. Tissue cultured C3H corneal epithelial and endothelial cells were administered orally to CB6F1 mice before or shortly after the application of orthotopic C3H corneal allografts. Cultured C3H corneal cells were conjugated with the non-toxic B subunit of cholera toxin as a means of preferentially inducing oral tolerance. Results--Ten oral doses of donor cells administered before keratoplasty reduced the incidence of corneal graft rejection from 100% in untreated hosts to 54% in orally tolerised mice. Conjugation of cholera toxin to corneal cells significantly enhanced the efficacy of oral tolerance such that only 9% of the mice fed 10 doses of cholera toxin conjugated cells rejected their corneal grafts. Even a single oral inoculation of corneal cells conjugated to cholera toxin was able to reduce corneal graft rejection by 36%. Conclusions--Oral administration of donor specific cells greatly enhances corneal graft survival. Use of cholera toxin adjuvant markedly enhances the efficacy of oral tolerance such that even a single oral dose of donor cells significantly reduces the incidence of rejection. The results support the clinical feasibility of this novel strategy for preventing immunological rejection of corneal transplants.

UR - http://www.scopus.com/inward/record.url?scp=0030707837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030707837&partnerID=8YFLogxK

M3 - Article

C2 - 9422933

AN - SCOPUS:0030707837

VL - 81

SP - 778

EP - 784

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 9

ER -